Original languageEnglish (US)
Title of host publicationHandbook of Clinical Nanomedicine
Subtitle of host publicationLaw, Business, Regulation, Safety, and Risk
PublisherPan Stanford Publishing Pte. Ltd.
Pages1253-1268
Number of pages16
Volume2
ISBN (Electronic)9789814669238
ISBN (Print)9789814669221
DOIs
StatePublished - May 2 2016

Fingerprint

Magnetite Nanoparticles
Nanomagnetics
Hypothermia
Ferrosoferric Oxide
Disease control
Medical nanotechnology
Polyethylene Terephthalates
Magnetic resonance imaging
Blood-Brain Barrier
Drug Delivery Systems
ferric oxide

Keywords

  • Alzheimer's disease (ad)
  • American society for nanomedicine (asnm)
  • Amyotrophic lateral sclerosis (als)
  • Bioimaging
  • Blood-brain barrier (bbb)
  • Drug targeting
  • Hiv
  • Hypothermia
  • Magnetic nanoparticles
  • Mri
  • Multiple sclerosis (ms)
  • Nanoneuromedicine
  • Nanotoxicity
  • Neurodegenerative disorders
  • Parkinson's disease (pd)
  • Pet
  • Small magnetite antiretroviral therapy (smart)
  • Superparamagnetic iron oxide (spio)
  • Theranostics
  • Therapeutic monitoring

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Engineering(all)
  • Materials Science(all)

Cite this

Gendelman, H. E., Mosley, R. L., Boska, M. D., & McMillan, J. M. (2016). The promise of nanoneuromedicine: An editorial. In Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk (Vol. 2, pp. 1253-1268). Pan Stanford Publishing Pte. Ltd.. https://doi.org/10.4032/9789814669238

The promise of nanoneuromedicine : An editorial. / Gendelman, Howard Eliot; Mosley, R Lee; Boska, Michael D.; McMillan, JoEllyn M.

Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk. Vol. 2 Pan Stanford Publishing Pte. Ltd., 2016. p. 1253-1268.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gendelman, HE, Mosley, RL, Boska, MD & McMillan, JM 2016, The promise of nanoneuromedicine: An editorial. in Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk. vol. 2, Pan Stanford Publishing Pte. Ltd., pp. 1253-1268. https://doi.org/10.4032/9789814669238
Gendelman HE, Mosley RL, Boska MD, McMillan JM. The promise of nanoneuromedicine: An editorial. In Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk. Vol. 2. Pan Stanford Publishing Pte. Ltd. 2016. p. 1253-1268 https://doi.org/10.4032/9789814669238
Gendelman, Howard Eliot ; Mosley, R Lee ; Boska, Michael D. ; McMillan, JoEllyn M. / The promise of nanoneuromedicine : An editorial. Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk. Vol. 2 Pan Stanford Publishing Pte. Ltd., 2016. pp. 1253-1268
@inbook{c2d9c07ac7dc4d43950a63d2142ef30b,
title = "The promise of nanoneuromedicine: An editorial",
keywords = "Alzheimer's disease (ad), American society for nanomedicine (asnm), Amyotrophic lateral sclerosis (als), Bioimaging, Blood-brain barrier (bbb), Drug targeting, Hiv, Hypothermia, Magnetic nanoparticles, Mri, Multiple sclerosis (ms), Nanoneuromedicine, Nanotoxicity, Neurodegenerative disorders, Parkinson's disease (pd), Pet, Small magnetite antiretroviral therapy (smart), Superparamagnetic iron oxide (spio), Theranostics, Therapeutic monitoring",
author = "Gendelman, {Howard Eliot} and Mosley, {R Lee} and Boska, {Michael D.} and McMillan, {JoEllyn M}",
year = "2016",
month = "5",
day = "2",
doi = "10.4032/9789814669238",
language = "English (US)",
isbn = "9789814669221",
volume = "2",
pages = "1253--1268",
booktitle = "Handbook of Clinical Nanomedicine",
publisher = "Pan Stanford Publishing Pte. Ltd.",

}

TY - CHAP

T1 - The promise of nanoneuromedicine

T2 - An editorial

AU - Gendelman, Howard Eliot

AU - Mosley, R Lee

AU - Boska, Michael D.

AU - McMillan, JoEllyn M

PY - 2016/5/2

Y1 - 2016/5/2

KW - Alzheimer's disease (ad)

KW - American society for nanomedicine (asnm)

KW - Amyotrophic lateral sclerosis (als)

KW - Bioimaging

KW - Blood-brain barrier (bbb)

KW - Drug targeting

KW - Hiv

KW - Hypothermia

KW - Magnetic nanoparticles

KW - Mri

KW - Multiple sclerosis (ms)

KW - Nanoneuromedicine

KW - Nanotoxicity

KW - Neurodegenerative disorders

KW - Parkinson's disease (pd)

KW - Pet

KW - Small magnetite antiretroviral therapy (smart)

KW - Superparamagnetic iron oxide (spio)

KW - Theranostics

KW - Therapeutic monitoring

UR - http://www.scopus.com/inward/record.url?scp=85015974282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015974282&partnerID=8YFLogxK

U2 - 10.4032/9789814669238

DO - 10.4032/9789814669238

M3 - Chapter

AN - SCOPUS:85015974282

SN - 9789814669221

VL - 2

SP - 1253

EP - 1268

BT - Handbook of Clinical Nanomedicine

PB - Pan Stanford Publishing Pte. Ltd.

ER -